Thus, in the present study, we sought to investigate the effects of XXMD on cerebral ischemia and reperfusion injury and to determine whether XXMD could attenuate BBB disruption by inhibiting the expression of MMP-9, MMP-2, and VEGF. The gene discussed is MMP9; the disease is Cerebral ischemia.